0001209191-23-029076.txt : 20230512
0001209191-23-029076.hdr.sgml : 20230512
20230512164142
ACCESSION NUMBER: 0001209191-23-029076
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230510
FILED AS OF DATE: 20230512
DATE AS OF CHANGE: 20230512
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kalb Michael Wayne
CENTRAL INDEX KEY: 0001678248
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40353
FILM NUMBER: 23916554
MAIL ADDRESS:
STREET 1: 24 LUCILLE LANE
CITY: DIX HILLS
STATE: NY
ZIP: 11746
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMPEL PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001445499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263058238
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0426
BUSINESS ADDRESS:
STREET 1: 201 ELLIOTT AVE. W
STREET 2: SUITE 260
CITY: SEATTLE
STATE: WA
ZIP: 98119
BUSINESS PHONE: 206-568-1466
MAIL ADDRESS:
STREET 1: 201 ELLIOTT AVE. W
STREET 2: SUITE 260
CITY: SEATTLE
STATE: WA
ZIP: 98119
FORMER COMPANY:
FORMER CONFORMED NAME: IMPEL NEUROPHARMA INC
DATE OF NAME CHANGE: 20080917
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-10
0
0001445499
IMPEL PHARMACEUTICALS INC
IMPL
0001678248
Kalb Michael Wayne
C/O IMPEL PHARMACEUTICALS INC.
201 ELLIOTT AVE W, STE 260
SEATTLE
WA
98119
0
1
0
0
CFO
0
Stock Option (right to buy)
2.43
2023-05-10
4
A
0
175000
0.00
A
2033-05-10
Common Stock
175000
175000
D
Restricted Stock Units (RSUs)
2023-05-10
4
A
0
47500
0.00
A
2033-05-10
Common Stock
47500
47500
D
The option vests as to 25% of the total shares on May 10, 2024 and then 1/48th of the total shares vests on each monthly anniversary thereafter, subject to the reporting person's provision of service to the issuer on each vesting date.
Each RSU represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
The RSUs vest as to 100% of the total shares on May 31, 2024, subject to the reporting person's continuation of employment on such vesting date.
/s/ Adrian Adams as attorney-in-fact
2023-05-12